| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.28197 |
| P698 | PubMed publication ID | 23564420 |
| P50 | author | Silvia Franceschi | Q56417107 |
| Joakim Dillner | Q62918677 | ||
| P2093 | author name string | Guglielmo Ronco | |
| Iacopo Baussano | |||
| Fulvio Lazzarato | |||
| P2860 | cites work | Achieving high coverage in Rwanda's national human papillomavirus vaccination programme | Q21034174 |
| Modelling the impact of antiretroviral use in resource-poor settings | Q25255753 | ||
| Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women | Q28251260 | ||
| Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity | Q33797578 | ||
| Human papillomavirus concordance in heterosexual couples | Q34257094 | ||
| Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections | Q34267472 | ||
| Role of herd immunity in determining the effect of vaccines against sexually transmitted disease | Q34380787 | ||
| The geographical and temporal evolution of sexually transmitted disease epidemics | Q34706391 | ||
| Sexual networks: implications for the transmission of sexually transmitted infections | Q35090034 | ||
| Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model | Q35235306 | ||
| Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine | Q35268615 | ||
| Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies | Q36148666 | ||
| Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women | Q36442227 | ||
| Sampling and sensitivity analyses tools (SaSAT) for computational modelling | Q36537766 | ||
| Economic evaluation of human papillomavirus vaccination in the United Kingdom | Q36818045 | ||
| HPV infection in women with and without cervical cancer in Conakry, Guinea | Q37269638 | ||
| An overview on the implementation of HPV vaccination in Europe | Q37829845 | ||
| High-throughput monitoring of human papillomavirus type distribution | Q37847498 | ||
| The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years | Q38383530 | ||
| Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries | Q38876141 | ||
| Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes | Q38889802 | ||
| Public health: Prevention comes of age. | Q38983571 | ||
| Modelling patterns of clearance of HPV-16 infection and vaccination efficacy | Q43946877 | ||
| Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom | Q43961793 | ||
| Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. | Q44133307 | ||
| Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
| Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial | Q49169372 | ||
| Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. | Q50627829 | ||
| Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. | Q51719830 | ||
| Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study | Q58280057 | ||
| Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys | Q58280379 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1876-1881 | |
| P577 | publication date | 2013-05-15 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries | |
| P478 | volume | 133 |
| Q40191017 | Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer |
| Q28601706 | Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective |
| Q40470651 | HPV vaccination: The most pragmatic cervical cancer primary prevention strategy. |
| Q46902171 | HPV-FASTER: broadening the scope for prevention of HPV-related cancer |
| Q27011403 | Infection transmission and chronic disease models in the study of infection-associated cancers |
| Q40855168 | Introduction of a National HPV vaccination program into Bhutan |
| Q57058900 | Modelling cervical cancer elimination |
| Q58279434 | Options for design of real-world impact studies of single-dose vaccine schedules |
| Q49990618 | Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14 year old girls against human papillomavirus |
| Q58816011 | Present challenges in cervical cancer prevention: Answers from cost-effectiveness analyses |
| Q39158741 | Progress in HPV vaccination in low- and lower-middle-income countries |
| Q59323037 | System dynamics model of cervical cancer vaccination and screening interventions in Kenya |
| Q38380092 | The next steps in cervical screening |
Search more.